CD44 expression during tumor progression of follicular lymphoma

Oncology Reports

Volumn 22, Issue 5, 2009, Pages 1135-1140

  Higashi, Morihiro ^a   Sugaya, Yoshiki ^a   Soeta, Satoshi ^a   Yokota, Akira ^a   Ishii, Genichiro ^a   Harigaya, Kenichi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD44; Follicular lymphoma; Immunohistochemistry; PCR; Tumor progression

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD44V ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; HERMES ANTIGEN; PROTEIN BCL 2;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BASE PAIRING; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOMA CELL; MOLECULAR EVOLUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE STUDY; SOUTHERN BLOTTING; UPREGULATION;

ANTIGENS, CD44; BLOTTING, SOUTHERN; DISEASE PROGRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, FOLLICULAR; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 70449377627     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000546     Document Type: Article

References (31)

1. Idzerda RL, Carter WG, Nottenburg C, Wayner EA, Gallatin WM and St John T: Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. Proc Natl Acad Sci USA 86: 4659-4663, 1989.
2. Neame SJ and Isacke CM: Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells. EMBO J 11: 4733-4738, 1992.
3. Lesley J, He Q, Miyake K, Hamann A, Hyman R and Kincade PW: Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med 175: 257-266, 1992.
4. Stamenkovic I, Aruffo A, Amiot M and Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10: 343-348, 1991.
5. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U and Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89: 12160-12164, 1992.
6. Brown TA, Bouchard T, St John T, Wayner E and Carter WG: Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 113: 207-221, 1991.
7. Goldstein LA, Zhou DF, Picker LJ, Minty CN, Bargatze RF, Ding JF and Butcher EC: A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56: 1063-1072, 1989.
8. Heider KH, Dammrich J, Skroch-Angel P, Muller-Hermelink HK, Vollmers HP, Herrlich P and Ponta H: Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53: 4197-4203, 1993.
9. Heider KH, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P and Pals ST: A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120: 227-233, 1993.
10. Charpin C, Garcia S, Bouvier C, Devictor B, Andrac L, Choux R, Lavaut MN and Allasia C: Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas. Hum Pathol 28: 289-296, 1997.
11. Matsumura Y and Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058, 1992.
12. Mueller JD, Heider KH, Oberhuber G, Mueller E, Bethke B, Stolte M and Hofler H: Comparison of CD44 expression in early colorectal carcinomas of the de novo and ex adenoma types. Virchows Arch 433: 407-414, 1998.
13. Mulder JW, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, Offerhaus GJ and Pals ST: Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 344: 1470-1472, 1994.
14. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H, Herrlich P and Pals ST: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754-4756, 1993.
15. Lukes RJ and Collins DR: Follicular center cell lymphomas, including Burkitt's lymphoma. Armed Forces Institute of Pathlogy, Washingtong DC, 1992.
16. Chen C, Chang MC, Hsieh RK, Chang YF, Lin J and Tsan KW: Activation of CD44 facilitates DNA repair in T-cell lymphoma but has differential effects on apoptosis induced by chemotherapeutic agents and ionizing radiation. Leuk Lymphoma 46: 1785-1795, 2005.
17. Tzankov A, Pehrs AC, Zimpfer A, Ascani S, Lugli A, Pileri S and Dirnhofer S: Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases. J Clin Pathol 56: 747-752, 2003.
18. Akisik E, Bavbek S and Dalay N: CD44 variant exons in leukemia and lymphoma. Pathol Oncol Res 8: 36-40, 2002.
19. Aguilera NS, Chu WS, Andriko JA and Abbondanzo SL: Expression of CD44 (HCAM) in small lymphocytic and mantle cell lymphoma. Hum Pathol 29: 1134-1139, 1998.
20. Bartolazzi A, Jackson D, Bennett K, Aruffo A, Dickinson R, Shields J, Whittle N and Stamenkovic I: Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci 108 (Pt 4): 1723-1733, 1995.
21. Horst E, Meijer CJ, Radaszkiewicz T, Ossekoppele GJ, Van Krieken JH and Pals ST: Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia 4: 595-599, 1990.
22. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P and Gunthert U: CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51: 5292-5297, 1991.
23. Stamenkovic I, Amiot M, Pesando JM and Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56: 1057-1062, 1989.
24. Lundgren E, Roos G, Nordenson I, Wahlin A and Lind J: Multiple DNA rearrangements in the BCL2 region in a patient with follicular lymphoma. Genes Chromosomes Cancer 3: 390-393, 1991.
25. Price CG, Tuszynski A, Watt SM, Murdoch SJ, Lister TA and Young BD: Detection of additional JH/BCL2 translocations in follicular lymphoma. Leukemia 5: 548-554, 1991.
26. Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RS and Dalla-Favera R: p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82: 2289-2295, 1993.
27. Lesley J and Hyman R: CD44 structure and function. Front Biosci 3: D616-D630, 1998.
28. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P and Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177: 897-904, 1993.
29. Moller P, Eichelmann A, Mechtersheimer G and Koretz K: Expression of beta 1-integrins, H-CAM (CD44) and LECAM-1 in primary gastro-intestinal B-cell lymphomas as compared to the adhesion receptor profile of the gut-associated lymphoid system, tonsil and peripheral lymph node. Int J Cancer 49: 846-855, 1991.
30. Hill RP: Metastasis. McGrow-Hill, New York, 1992.
31. Hofmann M, Rudy W, Gunthert U, Zimmer SG, Zawadzki V, Zoller M, Lichtner RB, Herrlich P and Ponta H: A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res 53: 1516-1521, 1993.